We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Patient-Friendly PET/CT System Provides Very Large Bore, Wide Field-of-View, and Fast Imaging

By HospiMedica International staff writers
Posted on 18 Jun 2014
A versatile new positron emission tomography/computed tomography (PET/CT) system combines high performance PET and CT for all radiation and oncology imaging requirements, including tumor detection, treatment evaluation, and CT simulation.

Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba Medical Systems’ (Tokyo, Japan) new Celesteion PET/CT system. More...


As healthcare reform in the United States puts a greater importance on patient satisfaction, the Celesteion’s patient-friendly features are designed for this new backdrop. These include a very large bores: 90-cm CT bore and 88-cm PET bore, providing a feeling of openness for patients, and more accurate CT and PET imaging; fast imaging for reduced exam times—PET has a 450 ps time-of-flight resolution and CT has a 0.5 second rotation with 0.5 mm detectors producing 32 slices; expansive field-of-view with 70-cm true CT and PET field-of-view and 85-cm CT extended field-of-view; and lastly, CT dose reduction ensures that patient safety comes standard with Toshiba’s CT dose reduction technology, AIDR (adaptive iterative dose reduction) 3D, for safer CT imaging, and is also compliant with Medical Imaging & Technology Alliance’s (MITA) XR-29 Smart Dose Standard. The system is pending US Food and Drug Administration (FDA) 510(k) clearance.

“By listening to our customers and understanding their business, we know there is a need for a PET/CT system that puts patients first, and the Celesteion is that solution,” said Satrajit Misra, senior director, CT business unit, Toshiba. “Accuracy and efficiency are crucial under healthcare reform, and Celesteion is capable of producing high quality images while improving workflow for providers.”

Toshiba’s Celesteion was presented for the first time at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting, June 7–11, 2014, in St. Louis (MO, USA).

Related Links:

Toshiba Medical Systems



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Infrared Digital Thermometer
R1B1
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.